Have posted this on the OH forum but still just in case anybody else knows the answer:
I know this was discussed earlier on this year but has anyone made any sense of it or am I dim?
https://www.nice.org.uk/guidan…/ng33/chapter/recommendations
Offer a Mantoux test to new NHS employees who are not new entrants from high-incidence countries and
have not had BCG vaccination (for example, they are without a BCG scar, other
documentation or a reliable history).
If the Mantoux test is positive, offer an interferon-gamma release assay. If this is positive,
assess them for active TB if this
assessment is negative, offer them treatment for latent TB.
(SO AM I RIGHT EITHER WAY IF THE MANTOUX IS POSITIVE AND THE IGRA IS POSITIVE OR NEGATIVE WE HAVE TO REFER THEM ON TO THE TB PEOPLE?)
Offer a Mantoux test to new NHS employees who are from a high-incidence country.
If the Mantoux test is positive (5 mm or larger, regardless of BCG history), assess for active
TB if this assessment is negative, offer them
treatment for latent TB infection
If Mantoux testing is unavailable, offer an interferon-gamma release assay.
If the interferon-gamma release assay is positive, assess for active TB and
If this assessment is negative, offer them treatment for latent TB infection .
(AGAIN WE HAVE TO REFER THEM ONTO THE TB PEOPLE).
Please correct me if i am wrong or have interpreted it incorrectly, if anyone has a dummies guide to the new guidence i would greatly appreciate it.
********************************
Please remove this footer before replying.
OCC-HEALTH ARCHIVES:
http://www.jiscmail.ac.uk/lists/occ-health.html
CONFERENCES AND STUDY DAYS:
http://www.jiscmail.ac.uk/cgi-bin/filearea.cgi?LMGT1=OCC-HEALTH
|